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In Brief
Dejarnac et al. find that the
phosphatidylserine receptor TIM-1 is a
bona fide DENV receptor that mediates
virus uptake through the clathrin-
mediated pathway. TIM-1 is ubiquitinated
at two lysines in its cytoplasmic tail and
interacts with STAM-1 for efficient DENV
infection.
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Dengue virus (DENV) is a major human pathogen
causing millions of infections yearly. Despite inten-
sive investigations, a DENV receptor that directly
participates in virus internalization has not yet
been characterized. Here, we report that the phos-
phatidylserine receptor TIM-1 is an authentic
DENV entry receptor that plays an active role in virus
endocytosis. Genetic ablation of TIM-1 strongly
impaired DENV infection. Total internal reflection
fluorescence microscopy analyses of live infected
cells show that TIM-1 is mostly confined in cla-
thrin-coated pits and is co-internalized with DENV
during viral entry. TIM-1 is ubiquitinated at two
lysine residues of its cytoplasmic domain, and this
modification is required for DENV endocytosis.
Furthermore, STAM-1, a component of the ESCRT-0
complex involved in intracellular trafficking of
ubiquitinated cargos, interacts with TIM-1 and is
required for DENV infection. Overall, our results
show that TIM-1 is the first bona fide receptor iden-
tified for DENV.
INTRODUCTION
Dengue is the most common mosquito-borne viral disease
caused by one of the four serotypes of dengue virus (DENV-1
to DENV-4). Almost half of the world population is at risk of infec-
tion, and about 100million new infections occur each year (Bhatt
et al., 2013). DENV infection causes pathologies ranging from a
self-limiting illness called dengue fever (DF) to the life-threat-
ening forms of dengue hemorrhagic fever (DHF) and dengue
shock syndrome (DSS) (Guzman and Harris, 2015). To date,
there is no specific treatment against DENV infection, and an
efficient human vaccine is not available.Ce
This is an open access article under the CC BY-NDENV enters target cells by receptor-mediated endocytosis.
Live-imaging studies have shown that DENV particles bind still
uncharacterized cellular receptor(s) and move along the cell
surface before being captured by preexisting clathrin-coated
pits (CCPs) for uptake by the endocytic machinery (van der
Schaar et al., 2007, 2008). The envelope glycoprotein (E pro-
tein), organized in 90 homodimers at the surface of DENV
particles (Kuhn et al., 2002), mediates virus attachment to cells
and fusion of viral and endosomal membranes. When internal-
ized, the low endosomal pH primes E protein for viral fusion
without the need for additional host factors (Stiasny et al.,
2011). Despite intensive investigations, an authentic receptor
that binds virions, participates in virus endocytosis, and
triggers infection has not been identified. A few molecules,
such as heparan sulfate aminoglycans (Chen et al., 1997) or
the C-type lectin DC-SIGN (Navarro-Sanchez et al., 2003; Tas-
saneetrithep et al., 2003), interact with the DENV E protein and
enhance infection (Perera-Lecoin et al., 2013). These mole-
cules are not directly involved in the DENV entry program but
mainly work as attachment factors, likely concentrating viral
particles at the vicinity of entry receptor(s) (Lozach et al.,
2005; Navarro-Sanchez et al., 2003; Tassaneetrithep et al.,
2003).
We have previously shown that DENV binding is independent
of interactions between E protein and target cells (Carnec et al.,
2015; Meertens et al., 2012). It involves the recognition of phos-
pholipids exposed at the surface of DENV by specific ‘‘eat me’’
receptors expressed on target cells. T cell immunoglobulin
mucin (TIM-1 and TIM-4) and the TAM (Tyro3 and Axl) receptor
families, along with CD300a, are themain receptors that mediate
DENV infectious entry (Carnec et al., 2015; Meertens et al.,
2012). Their natural function is to interact with phosphatidylser-
ine (PS) or phosphatidylethanolamine (PE) exposed on apoptotic
cells to promote their phagocytosis (Kobayashi et al., 2007;
Lemke and Rothlin, 2008; Leventis andGrinstein, 2010; Simhadri
et al., 2012). DENV hijacks this process for entry and mimics
apoptotic cell bodies by exposing PS and PE at the viral
membrane (Carnec et al., 2015; Meertens et al., 2012). Thisll Reports 23, 1779–1793, May 8, 2018 ª 2018 The Author(s). 1779
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Genetic Ablation of TIM-1 Inhibits DENV Infection
(A) TIM-1 expression in human skin.
(B) TIM-1 cell surface expression in TIM-1 KO cells (red line). Gray shading represents cell staining with a control antibody and the blue line TIM-1 expression in
control cells.
(C) Control and TIM-1 KO cell lines were challenged with DENV2 JAM (MOI 1) or HSV-1 (MOI 0.2).
(D) A549 CRISPR control and TIM-1 KO cells were challenged with DENV1, DENV4, WNV, or ZIKV. The levels of infected cells were assessed 24 hours post
infection (hpi) by flow cytometry using the respective anti-viral antibodies. Data shown are means ± SD of two independent experiments in duplicate.
(E) A549 control and TIM-1 KO cells were incubated on ice with DENV2 JAM at an MOI of 50. Cells were then stained for DENV viral RNA (red). White lines outline
the cell membrane. Data shown on the left are representative of two independent experiments. Scale bar, 20 mm. Right: quantification of DENV RNA spots
counted per cells for each condition (n > 20).
(F) A549 TIM-1 KO and control cells were incubated with DENV2 JAM for 1 hr at 4C and shifted to 37C for 2 hr. Cells were then treated with proteinase K
(1 mg/mL) for 45 min at 4C, total RNA was extracted, and relative viral RNA was quantified by qRT-PCR. Data shown are representative of two independent
experiments.
Significance was calculated using a two-sample Student’s t test (D, F, and G) or a one-way ANOVA statistical test with a Tukey post-test (E). n.s., non-significant;
**p < 0.001; ***p < 0.0001.
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viral apoptotic mimicry strategy may be exploited by flavivi-
ruses and other viruses, probably to broaden viral tropism
and escape innate immunity (Amara and Mercer, 2015; Bhatta-
charyya et al., 2013; Hamel et al., 2015; Jemielity et al., 2013;
Kondratowicz et al., 2011; Meertens et al., 2017; Mercer and
Helenius, 2008; Moller-Tank et al., 2013; Morizono and Chen,
2014; Shimojima et al., 2006; Vanlandschoot and Leroux-Roels,
2003).
TIM-1 is a type I transmembrane glycoprotein with an extra-
cellular domain composed of an N-terminal immunoglobulin V
(IgV)-like domain followed by a glycosylated mucin domain, a
transmembrane domain, and a short cytoplasmic tail (Freeman
et al., 2010). A conserved cavity within the IgV-like domain,
called the metal ion-dependent ligand-binding site (MILIBS),
is the binding site for PS (Kobayashi et al., 2007; Santiago
et al., 2007). TIM-1 enhances infection by the four DENV
serotypes and related flaviviruses (Hamel et al., 2015; Meert-
ens et al., 2017). TIM-1 expression correlates with cell
permissiveness to DENV infection (Meertens et al., 2012).
DENV infection of permissive cells is inhibited by anti-TIM-1
antibodies or by silencing expression of this receptor with
RNAi (Meertens et al., 2012). TIM-1 interacts directly with
DENV particles, and mutations of highly conserved amino
acids (TIM-1 N114A or D115A and TIM-4 N121A) lining the
MILIBS abolish infection (Meertens et al., 2012). Moreover,
annexin V, which binds PS, inhibits TIM-mediated enhance-
ment of infection (Meertens et al., 2012). TIM-1 enhances
DENV internalization (Meertens et al., 2012) through mecha-
nisms that are not characterized. TIM-1 is constitutively inter-
nalized by clathrin-mediated endocytosis (Balasubramanian
et al., 2012), the major DENV entry route (Acosta et al.,
2008, 2009; van der Schaar et al., 2008). One important
question concerning TIM-1 is whether this molecule serves
as an authentic DENV endocytic receptor or whether it only
enhances virus attachment.
Here we have studied the molecular mechanisms of TIM-1-
mediated DENV infection in several cellular models. We show
that TIM-1 plays an active role in viral endocytosis and that it is
the first bona fide entry receptor identified for DENV.Figure 2. TIM-1 and DENV Co-internalized through CME
(A) Confocal microscopy analysis of TIM-1 and transferrin internalization. HeLa TI
antibody for 1 hr at 4C and shifted to 37C. At the indicated time points, cells
488-conjugated secondary antibody. Scale bars, 10 mm. Pearson correlation co
representative of at least three independent experiments.
(B and C) HeLa TIM-1-expressing cells were transfected with a siRNA pool target
expression of TIM-1 and CD71 was assessed 48 hr after transfection by flow cyto
Data shown are means ± SD of two independent experiments.
(D) Confocal microscopy analysis of TIM-1 and DENV2 internalization. HeLa pare
anti-TIM-1 primary antibody for 1 hr at 4C and shifted to 37C. At the indicated
immunostained with a goat anti-mouse Alexa 488-conjugated secondary antibod
experiments.
(E) Transmission electron microscopy and immunogold labeling of TIM-1 and DE
electron microscopy, showing endocytosis of DENV particles mediated by clathr
(6-nm gold particles, small arrows) and DENV-E (10-nm gold particles, large ar
vesicles containing DENV particles. PM, plasma membrane. Scale bars, 100 nm
(F) TIM-1-expressing cells were transfected with dominant-negative (DN) forms o
GFP control plasmids. Cells were challenged with DENV2 JAM 24 hr after tran
GFP-positive population. Data shown are means ± SD of two independent expe
For (B) and (E), significance was calculated using one-way ANOVA statistical tes
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TIM-1 Is an Important Cellular Receptor for DENV
Infection
To study the role of TIM-1 in DENV infection, we first examined its
localization in human skin, the entry site of the virus during the
mosquito bite. TIM-1 is expressed on human keratinocytes
located at basal layer of the skin epidermis and is not detected
in other regions (Figure 1A). Gain-of-function studies showed
that ectopic TIM-1 expression in several non-permissive cells
confers DENV infection (Figure S1). To prove that endogenous
TIM-1molecules are important for DENV infection, we generated
TIM-1 knockout A549, Huh7.5, and 769P cells by CRISPR/Cas9
(Figure 1B). DENV2 infection was significantly inhibited in cells
lacking TIM-1 (Figure 1C), whereas herpes simplex virus 1
(HSV-1) infection was not affected. TIM-1 was also required for
productive infection of A549 cells by other DENV serotypes,
West Nile virus (WNV) and Zika virus (ZIKV) (Figure 1D). We
then performed a fluorescence in situ hybridization (FISH) assay
to detect virus binding at the cell surface (Figure 1E). TIM-1 plays
an essential role in DENV capture because very little viral RNA
(vRNA) was detected in Huh7.5 TIM-1 knockout (KO) cells
compared with control cells. Consistently, the amount of inter-
nalized DENV RNA was significantly reduced in TIM-1 KO cells
compared with control cells (Figure 1F). Altogether, these data
show that TIM-1 promotes DENV binding and infection in various
human cell lines. Of note, residual viral binding and infection
were observed in TIM-1 KO cells, suggesting that TIM-1 is the
main but not the only receptor for DENV.
TIM-1 and DENV Are Co-internalized during Virus Entry
To investigate TIM-1 trafficking in human cells, we performed
immunofluorescence staining of TIM-1 and AF594-conjugated
transferrin (Tf) in different cell types (Figure S2A). Consistent
with a previous study (Balasubramanian et al., 2012), confocal
microscopy studies showed that a large proportion of TIM-1
molecules exist in intracellular pools that co-localize with Tf.
This suggests that TIM-1 is constitutively internalized through
clathrin-mediated endocytosis (CME), the major DENV entryM-1 cells were incubated with transferrin-AF594 and mouse anti-TM-1 primary
were fixed, permeabilized, and immunostained with a goat anti-mouse Alexa
efficients (PCCs) were calculated using ImageJ software (n = 5). Images are
ing clathrin heavy chain (CHC) or a non-targeting (NT) siRNA pool. Cell surface
metry (B) or by confocal microscopy (C) under non-permeabilized conditions.
ntal or TIM-1-expressing cells were incubated with DENV2 AF594 and mouse
time points, cells were treated or not treated with trypsin, permeabilized, and
y. Scale bars, 10 mm. Images are representative of at least three independent
NV particles in infected cells. Top: images obtained by standard transmission
in-coated vesicles (scale bars, 100 nm). Bottom: immunogold labeling of TIM1
rows) in cryosections. TIM-1 is localized at the membrane of clathrin-coated
.
f EGFP-dynamin (Dyn K44) and -Eps15 (Eps15 D95-215) or with the respective
sfection. For each sample, infection was quantified by flow cytometry in the
riments.
t with Tukey post-test (*p < 0.01, **p < 0.001.
(legend on next page)
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route for productive infection (Acosta et al., 2008; van der Schaar
et al., 2008). To study the kinetics of TIM-1 internalization from
the cell surface, HeLa TIM-1 cells were co-incubated with satu-
rating concentrations of a non-neutralizing anti-TIM-1 mono-
clonal antibody (mAb) and AF594-Tf for 1 hr at 4C. Cells were
either kept on ice (0 min) or shifted at 37C to allow endocytosis
and then analyzed at various time points. Internalized TIM-1/anti-
TIM-1 complexes were detected using a fluorescent secondary
antibody (Ab) under permeabilized conditions. At 0 min, TIM-1/
anti-TIM complexes were mainly detected at the cell surface
(Figure 2A). Upon internalization, the majority of TIM-1 receptor
co-localized with Tf (Figure 2A). To confirm that TIM-1 traffics
through CME, the expression of clathrin heavy chain (CHC)
was knocked down using RNAi. Under these conditions, TIM-1
accumulated at the cell surface, similar to the CD71 Tf receptor,
which is known to be internalized via CME (Figures 2B and 2C).
We then studied TIM-1 and DENV localization in fixed cells
using confocal microscopy. We generated Alexa Fluor
594-labeled DENV2 particles (DENV2 AF594). DENV labeling
did not affect infectivity (Figure S2B) or binding to TIM-1 (Fig-
ure S2C). Inside-out staining experiments showed that the vast
majority of TIM-1 Abs co-localized with DENV2 AF594 during
viral entry (Figure 2D), strongly suggesting that they are co-inter-
nalized. Electron microscopy studies supported these finding
and showed that, in TIM-1-positive cells, DENV enters via CME
(Figure 2E). Furthermore, both the virus and receptor trafficked
together during endocytosis and were located in the same
endosomal compartments (Figures 2D and 2E; Figure S2D).
TIM-1-mediated DENV infection was abrogated in HeLa TIM-1
cells knocked down for CHC expression (Figure S2E) or by
ectopically expressing the dominant-negative (DN) forms of
Eps15 and Dynamin, two cellular proteins essential for CME
(Figure 2F). Therefore, TIM-1 mediates DENV endocytosis and
is co-internalized with viral particles through CME.
Dynamics of TIM-1-Mediated DENV Internalization
To study the dynamics of TIM-1 at the plasma membrane, total
internal reflection fluorescence (TIRF) microscopy experiments
were performed in live cells. TIRF microscopy generates an
evanescent field that penetrates100 nm deep into cells; there-
fore, only cell surface molecules are excited by the laser and can
emit a fluorescent signal. This approach is particularly well suited
to analyze the localization and the dynamics of molecules and
events near the plasma membrane in living cells (Poulter et al.,Figure 3. Live Imaging of TIM-1 and DENV AF594 Co-Internalization by
(A) TIRF image of HeLa cells stably expressing TIM-1 GFP. Scale bar, 10 mm.
(B) Motility and trajectory analysis of the TIM-1-GFP receptor at the plasma mem
7,490 tracks. 76.2% of spots were found to be confined (blue), 5.0% diffusive (g
(C) Representative graph of TIM-1 GFP mobility at the plasma membrane.
(D) HeLa TIM-1 GFP (green) cells were transfected with clathrin light chain-dsRed
bar, 2 mm.
(E) Representative graph of TIM-1 GFP movement when found co-localized with
total spots tracked (n = 120).
(F) HeLa TIM-1 GFP cells were imaged by TIRF microscopy in the continuous pr
(G) Distribution of tracked TIM-1 spots that co-localized and internalized DENV2 A
(H) Time-lapse series images of TIM-1-GFP (green) and DENV2 AF594 (red) simu
(I) Magnification of TIM-1-GFP (green) and DENV2 AF594 (red) trajectories obtain
(J) Respective average fluorescence intensity of TIM-1-GFP (green) and DENV2
1784 Cell Reports 23, 1779–1793, May 8, 20182015). We generated a HeLa cell line that stably expresses
TIM-1 fused to the GFP. TIM-1 GFP protein exhibited a similar
cellular localization as the wild-type (WT) receptor and enhanced
DENV infection with similar efficiency (Figures S3A and S3B).
TIRF microscopy analysis showed that TIM-1 GFP puncta
displayed distinct dynamic dots at the plasma membrane (Fig-
ure 3A). Using TrackMate and MATLAB software, we analyzed
7400 TIM-1 GFP spots trajectories from 10 cells. TIM-1 exhibited
three different types of motions at the cell surface (Figure 3B).
Although the majority of TIM-1 stayed confined within a limited
area of the plasma membrane (76%), the remaining portion
was either transported across the cell surface (19%) or diffusive
at the plasma membrane (5%) (Figures 3B and 3C). Because
TIM-1 internalizes through CME, we determined whether these
confined TIM-1 molecules were associated with CCPs. TIRF
studies performed with TIM-1 GFP cells transiently expressing
dsRed-clathrin light chain (CLC) (Figure 3D) showed that the ma-
jority of TIM-1 spots that co-localized with CLC displayed a
confined displacement (Figure 3E). These data strongly suggest
that TIM-1 is mostly confined in CCPs at the plasma membrane.
To record virus internalization in live cells, dual-color TIRF
images were acquired at 37C immediately after DENV2 AF594
addition to the culture medium of HeLa TIM-1 GFP cells. The
small size of DENV particles (50–60 nm in diameter) allowed virus
diffusion into the narrow space between the cell and the cover-
slip. The dynamic of viruses bound to the bottom of the cells
was thus accessible via TIRF imaging (Figure 3F). Robust individ-
ual viral particle tracking requires high-speed imaging and low
particle density. We therefore exposed cells to DENV2 AF594
at an MOI of 1 and immediately acquired images every second
for 20–40 min. The dynamics of 27 DENV particles (in 8 cells)
that associated with TIM-1 GFP were recorded. The majority of
TIM-1 GFP dots tracked for DENV2 internalization displayed
confined displacement at the plasma membrane (Figure 3G).
The trajectories of these 27 events were analyzed (Figure S3C),
and one representative track is shown in Figure 3H. In 6 cases,
DENV particles exhibited lateral movements in the TIRF field,
followed by confined movement when associated with TIM-1
(Figure 3I). Such behavior suggests that DENV may interact
with another attachment factor before binding to TIM-1. In
16 cases, DENV2 AF594 and TIM-1 GFP trajectories perfectly
overlapped from the beginning of acquisition to the disappear-
ance of the DENV-TIM-1 complexes from the field. In 5 of these
recordings, both DENV and TIM-1 exhibited lateral movementsTIRF Microscopy
brane. Analysis was done on 9 different TIRF microscopy videos and a total of
reen), and 18.9% transported (red). Scale bar, 500 nm.
(clathrin LC-DsRed, red) 48 hr before live imaging by TIRF microscopy. Scale
clathrin LC-dsRed (Red positive). Data are representative of the percentage of
esence of DENV2 AF594. Scale bar, 2 mm.
F594. Data are representative of the percentage of total spots tracked (n = 27).
ltaneously disappearing from the TIRF field. Scale bar, 0.5 mm.
ed from the spots tracked in (H).
AF594 (red) over time from the spot tracked in (H).
(legend on next page)
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within the plasma membrane, and then a confined trajectory
occurred when they associated (Figure S3C). The mean fluores-
cence intensities corresponding to DENV2 AF594 (red) and
TIM-1 GFP (green) were also measured over time (Figure 3J).
The fluorescence intensities of the two signals decreased in
parallel, suggesting concomitant internalization of DENV2
AF594 and TIM-1 GFP from the plasma membrane. These data
also suggest that the interaction between DENV2 AF594 and
TIM-1 GFP may be long-lasting and/or very strong; when the
virus and TIM-1 GFP are associated, they remained bound until
both signals simultaneously disappear from the field (Figure 3J).
On average, DENV particles stayed in the TIRF field for about
40 s (with variation from 8 to 150 s). Together, TIRF microscopy
analyses further demonstrate that TIM-1 and DENV particles
interact at the plasma membrane and suggest that this interac-
tion most likely drives virus internalization.
The TIM-1 Cytoplasmic Domain Is Important for DENV
Internalization
TIM-1 promotes DENV internalization; however, the exact
molecular and cellular mechanisms involved are unknown. To
investigate whether the TIM-1 cytoplasmic domain is required
for endocytosis, we generated HeLa cells stably expressing
TIM-1 lacking this domain (TIM-1 Dcyt) (Figure 4A). Cells were
incubated with anti-TIM-1 Abs, shifted at 37C for 20 min, and
then permeabilized or not with saponin to discriminate surface
from internalized TIM-1 receptors (Figure 4B). At 4C, both
TIM-1 WT and TIM-1 Dcyt were localized at the plasma mem-
brane. When cells were incubated at 37C, the WT molecule
was efficiently internalized, whereas TIM-1Dcytmainly remained
at the cell surface (Figures 4B and S4A). The cytoplasmic domain
of TIM-1 is thus required for TIM-1 constitutive endocytosis. We
previously showed that DENV infection is modestly reduced in
HEK293T cells overexpressing the TIM-1 Dcyt mutant (Meertens
et al., 2012). We confirmed these results in cells that stably
express this molecule. The TIM-1 Dcyt mutant bound DENV par-
ticles with similar efficiency as its WT counterpart (Figure 4C).
DENV2 infection was strongly impaired in cells expressing
TIM-1 Dcyt, whatever the MOI tested (Figure 4D). Similar results
were obtained with another DENV serotype (DENV3 THAI) in
HEK293T cells expressing TIM-1 WT or the Dcyt mutant (FiguresFigure 4. The TIM-1 Cytoplasmic Domain Is Essential for TIM-1-Media
(A) Surface expression of TIM-1 in HeLa cells stably expressing WT or Dcyt muta
(B) Confocal microscopy of TIM-1WT and Dcyt mutant endocytosis. Cells were in
shifted to 37C for 20 min. Cells were fixed and stained with secondary goat anti-
Images are representative of at least three independent experiments.
(C) DENV2 binding quantification by qRT-PCR on parental, TIM-1 WT, or Dcyt-ex
washed extensively. Total RNA was extracted, and relative viral RNA was quantifie
(D) DENV2 infection of parental, TIM-1 WT, and TIM-1 Dcyt mutant HeLa cells. C
infection was assessed 24 hpi by flow cytometry. Data are shown as mean ± SD
(E) Parental, TIM-1 WT, or TIM-1 Dcyt-expressing HeLa cells were incubated on
treated or not treated with trypsin for 15 min at 4C. Cells were then fixed, per
membrane. Scale bars, 10 mm. Images are representative of three independent e
(F) Parental, TIM-1 WT, or Dcyt-expressing HeLa cells were incubated with DENV
control. Cells were treated with trypsin to remove cell surface-bound DENV2 AF5
using Fiji software. Data are shown as mean ± SD of at least three independent
(G) Quantification of DENV2 AF594 particles internalized in live HeLa TIM-1WT or
by spinning disk live microscopy (n = 3). Data are shown as mean ± SD for each
Significance was calculated using one-way ANOVA (C, D, and F) or a two-samp
1786 Cell Reports 23, 1779–1793, May 8, 2018S4B and S4C). To investigate the ability of the TIM-1Dcyt mutant
to promote DENV endocytosis, we visualized and quantified viral
internalization using multiple methods. First, we incubated
parental, TIM-1 WT, or TIM-1 Dcyt-expressing cells with
DENV2 at 4C to synchronize viral binding and then shifted
them to 37C for 30 min to allow viral internalization. Cells were
then treated with trypsin to eliminate viral particles remaining
at the cell surface, and vRNA was detected by FISH (Figure 4E).
In a second approach, we incubated parental and TIM-1-ex-
pressing cells with DENV2 AF594 and quantified virus binding
and endocytosis using Fiji software. As expected, TIM-1 WT
and TIM-1 Dcyt similarly bound DENV2 AF594 particles (Fig-
ure 4F, 0 min (4C) –trypsin). Trypsin removed the signal at the
cell surface (Figure 4F, 0 min (4C) +trypsin). However, after
30 min at 37C, TIM-1 Dcyt cells showed a strong defect in viral
particle internalization compared with TIM-1WT cells (Figures 4F
and S4D). We then recorded DENV2 AF594 internalization in live
cells using spinning disk confocal microscopy. Using Fiji and
TrackMate, we quantified the number of internalized DENV2
AF594 particles every 2 s for up to 20 min (Figure 4G, red
dots). This assay also indicated that the cytoplasmic tail of
TIM-1 is important for DENV endocytosis. Interestingly, TIM-1
Dcyt mediated internalization of apoptotic thymocytes, similar
to TIM-1 WT or a TIM mutant expressing a GPI anchor (Figures
S4E–S4G). Taken together, these data show that the TIM-1 cyto-
plasmic domain is essential for DENV endocytosis but not for
phagocytosis of apoptotic cells.
TIM-1 Ubiquitination Regulates DENV Endocytosis
The TIM-1 cytoplasmic tail does not contain any canonical endo-
cytic domains such as di-leucine or tyrosine-based motifs. We
noticed the presence of two lysines (K338 and K346) located in
the TIM-1 cytoplasmic region that may act as ubiquitination sites
(Figure 5A). Ubiquitin (Ub) is a post-translational modification
reported to promote receptor endocytosis and target receptors
for lysosomal degradation and termination of receptor signaling
(Haglund and Dikic, 2012; Shih et al., 2000). To investigate
whether TIM-1 is ubiquitinated, we generated HeLa cells
expressing mutants of the cytoplasmic tail of TIM-1 in which
single or both lysine residues at position 338 and 346 were
substituted with arginines (K338R, K346R, and KKRR) (Figure 5B).ted DENV Infection and Internalization
nt TIM-1.
cubated with primary mouse anti-TIM-1 antibody (30 mg/mL) for 1 hr at 4C and
mouse Alexa 488-conjugated antibody in the presence or absence of saponin.
pressing HeLa cells. Cells were incubated with DENV2 JAM for 1 hr on ice and
d by qRT-PCR. Data shown are means ± SD of two independent experiments.
ells were challenged with DENV2 JAM at the indicated MOI, and the level of
of at least three independent experiments.
ice with DENV2 JAM at a MOI of 50. Cells were shifted at 37C for 60 min and
meabilized, and stained for DENV viral RNA (red). White lines outline the cell
xperiments.
2 AF594 for 1 hr on ice and then shifted to 37C for 30 min or kept at 4C as a
94 particles. DENV2 AF594 particles were quantified by immunofluorescence
experiments (n > 150 cells for each condition).
HeLa TIM-1Dcyt cells over time. Quantification was done from videos recorded
time point.
le Student’s t test (G); ***p < 0.0001.
(legend on next page)
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We immunoprecipitated these proteins to assess their ubiquiti-
nation status. Immunoblot analysis using a FK2 Ab, which recog-
nizes mono- and polyubiquitinated proteins, showed that both
the K338 and K346 residues are required for TIM-1 ubiquitination
(Figure 5C). A proximity ligation assay (PLA) using anti-TIM-1 and
FK2 Abs allowed visualization of the association of Ub with the
WT molecule but not with Dcyt and KKRR TIM-1 (Figure 5D).
Therefore, the two K338 and K346 residues are essential for
TIM-1 ubiquitination. We then challenged cells expressing
TIM-1 mutants with DENV2 JAM and quantified viral infection
by flow cytometry (Figure 5C). TIM-1 K338R promoted DENV2
infection less efficiently than TIM-1 WT. The TIM-1 K346R and
KKRR double mutants were even more impaired (Figure 5E).
To analyze whether TIM-1 ubiquitination affects DENV internali-
zation, we quantified, by qRT-PCR, the levels of vRNA internal-
ized after 2 hr at 37C. The mutant TIM-1 KKRR internalized
significantly fewer viral particles than the WT molecule (Fig-
ure 5F). TIM-1 WT and mutant-expressing cells bound DENV2
AF594 particles with similar efficiency (Figure S5A). Trypsin
treatment removed cell surface-bound viral particles at 4C (Fig-
ure S5A). After 30 min at 37C, viral particles were mostly
detected only in HeLa cells expressing TIM-1 WT, whereas
TIM-1 Dcyt and TIM-1 KKRR mutants internalized significantly
fewer viral particles (Figure 5G; Figure S5A). We further
confirmed these results using vRNA detection by FISH. Quanti-
fication of internalized DENV RNA dots (red) demonstrated that
vRNA was significantly less endocytosed in cells expressing
the KKRR mutant compared with TIM-1 WT (Figure 5H). Of
note, we observed that the TIM-1 Ub profile was unaffected by
DENV during entry (Figure S5B). We then analyzed, by TIRF
microscopy, the motility of DENV2 AF594 at the plasma mem-
brane in TIM-1 WT, Dcyt-, or KKRR-expressing cells (Figure 5I).
With TIM-1WT, viruses were first observed at the edge of the cell
(Figure S5C). After 5–6 min, the entire cell surface was covered
with viruses, suggesting that they were diffusing laterally prior
to endocytosis. By contrast, no lateral transport was observedFigure 5. Ubiquitination of the TIM-1 Cytoplasmic Domain Is Required
(A) Amino acid sequence of the TIM-1 cytoplasmic domain. The two mutated lys
(B) Cell surface expression of the TIM-1 receptor in TIM-1 WT, TIM-1 Dcyt, and
represents cells stained with a control antibody.
(C) Ubiquitination profile of WT or mutant TIM-1 was monitored with the FK2 ant
(D) Proximity ligation assay (Duolink) was performed in parental, TIM-1WT, TIM-1
FK2 antibodies. Positive interactions between ubiquitin and the TIM-1 receptor
experiments. Scale bars, 10 mm.
(E) Parental or TIM-1 mutant-expressing HeLa cells were challenged with DENV2
Data are shown as mean ± SD of three independent experiments.
(F) Parental, TIM-1 WT, TIM-1Dcyt-, or TIM-1 KKRR-expressing HeLa cells were
proteinase K for 45 min at 4C to remove cell surface-bound particles. Internaliz
(G) Parental, TIM-1WT, TIM-1Dcyt-, or TIM-1 KKRR-expressing HeLa cells were in
4C as a control. Cell surface-bound particles were eliminated with trypsin treatm
shown are mean ± SD of at least three independent experiments (n > 150).
(H) Parental, TIM-1WT, or TIM-1 KKRRHeLa cells were incubated on icewith DEN
treated with trypsin for 15min at 4C. Cells were then fixed and stained for DENV v
of at least three independent experiments (n > 30). Scale bars, 10 mm. Right: qu
software.
(I) Fluorescent DENV2 AF594 particles were added to HeLa TIM-1 GFP, TIM-1Dc
and viral particles (spots) inside the yellow line were quantified over time using F
cells. Dot quantifications are representative of five independent experiments.
For (E)–(H), significance was calculated using one-way ANOVA; **p < 0.001, ***p
1788 Cell Reports 23, 1779–1793, May 8, 2018in the presence of TIM-1mutants (Figure 5I; Figure S5C). Consis-
tent with these data, electron microscopy studies indicated that
TIM-1 WT is expressed at the cell membrane and also detected
in multivesicular bodies (MVBs), whereas the TIM-1 KKRR
mutant was mainly detected at the plasma membrane (Fig-
ure S5C). Together, these data indicate that TIM-1 ubiquitination
regulates DENV lateral motility at the cell surface, internalization,
and productive infection.
Proteomics Analysis of TIM-1 Cellular Partners
Identifies STAM as a Host Factor for DENV Infection
To uncover the host factors that associated with TIM-1 during
DENV internalization, we generated HeLa cells stably expressing
a molecule carrying a double FLAG and hemagglutinin (HA) tag
at the end of the cytoplasmic tail (TIM-1 FLAG-HA; Figure S6A).
This tagged form of TIM-1 enhanced DENV infection as effi-
ciently as TIM-1 WT (Figure S6B). HeLa cells expressing TIM-1
WT or TIM-1 FLAG-HA were then differentially labeled with sta-
ble isotope labeling with amino acids (SILAC) and lysed. The
two lysates were pooled equally, and two successive immuno-
precipitations using beads coupled with anti-FLAG M2- and
anti-HA-specific IgG were used to purify TIM-1 FLAG-HA (Fig-
ure S6C). Co-precipitated proteins were purified by SDS-PAGE
(Figure S6D) and analyzed by mass spectrometry. We defined
a threshold > 2 according to the isotope ratio 13C/12C (Table 1).
Above this threshold, we identified 22 host proteins (Table 1).
Among them, FYN, a previously known TIM-1 binding partner
(Curtiss et al., 2011), was detected, validating our approach.
We then analyzed the protein-protein interaction network of
the identified TIM-1 binding factors using the STRING database
(Figure S6E). This analysis highlighted an important network of
proteins implicated in the regulation of protein ubiquitination,
including four E3 Ub ligases (ITCH, RNF149, STUB1, and
NEDD4L), receptor trafficking, and endosomal sorting proteins
(Table 1; Figure S6E). We then performed a loss-of-function
screening to determine the effect of each factor in DENVfor DENV Infection and Internalization
ine residues are indicated in bold red letters.
K338R, K346R or KKRR mutants stably expressed in HeLa cells. Gray shading
ibody.
Dcyt-, or TIM-1 KKRR-expressing HeLa cells using goat anti-TIM-1 andmouse
are represented by red spots. Images are representative of two independent
JAM at the indicated MOIs. Infection was quantified 24 hpi by flow cytometry.
incubated with DENV2 for 1 hr on ice, shifted to 37C for 2 hr, and treated with
ed DENV viral RNA was quantified by qRT-PCR.
cubated with DENV2 AF594 for 1 hr on ice, shifted to 37C for 30min, or kept at
ent. DENV2 AF594-bound particles were quantified using Fiji software. Data
V2 JAM at anMOI of 50. Cells were shifted to 37C for 60min and treated or not
iral RNA (red). White lines outline the cell membrane. Images are representative
antification of spot number per cell obtained from FISH images using ImageJ
yt GFP, or TIM-1 KKRR GFP at 37C. Cells were imaged by TIRF microscopy,
iji software from the different videos recorded. Yellow lines outline the edge of
< 0.0001.
Table 1. A Subset of TIM-1-Associated Proteins Identified by
SILAC Differential Proteomics
Protein Name
Number of
Peptides
Molecular
Weight (kDa)
SILAC Labeling
(Ratio H/L)
TNFRSF10B 3 47.88 11.9
ACVR1B 2 56.81 9.83
DDR2 3 96.74 7.46
TGFBR1 20 55.96 6.7
NDFIP1 4 24.90 5.36
STUB1 2 34.86 4.44
ABCG2 8 72.31 4.42
SNX17 3 52.90 4.18
PI4K2A 5 51.02 4.03
UBA52 54 14.73 4.01
ATP1A1 207 112.90 3.56
SLC12A3 3 113.14 3.54
SNX6 4 46.65 3.24
ATP1B1 14 35.06 3.15
ITCH 3 102.80 3.12
FYN 7 60.76 3.11
STAM 3 59.18 2.62
TFRC 107 84.87 2.57
YWHAE 23 29.17 2.56
WWP2 3 98.91 2.44
DNAJA3 5 52.49 2.39
NEDD4L 3 111.93 2.36
HeLa TIM-1 and HeLa TIM-1 FLAG-HA cells were differentially labeled
with the SILAC method. TIM-1-associated proteins were sequentially
co-precipitated with FLAG and HA. The specificity threshold of TIM-1 as-
sociation from individual identified protein was defined as a peak volume
ratio H/L > 2 of the differentially isotope-labeled versions of each protein.infection. We silenced the expression of each of these factors by
RNAi and investigated their effect on DENV infection (Fig-
ure S6F). This RNAi screen identified UBA52, ITCH, and
STAM-1 as TIM-1 partners required for DENV infection (Fig-
ure S6F). We focused our work on STAM-1, one of the two com-
ponents of ESCRT-0 implicated in endosomal sorting of ubiqui-
tinated receptors (Haglund and Dikic, 2012). STAM-1 interacts
with TIM-1 WT but to a lesser extend with TIM Dcyt or TIM
KKRRmutants (Figure 6A).We then stained STAM-1 by immuno-
fluorescence and observed a marked co-localization with TIM-1
GFP in HeLa cells (Figure 6B). This suggested that TIM-1 traffics
through STAM-1-positive endosomes. Moreover, silencing
STAM-1 with small interfering RNA (siRNA) (Figure 6C) dimin-
ished TIM-1 cell surface expression (Figure 6D) and inhibited
DENV binding and endocytosis (Figure 6E). Depletion of
STAM-1 inhibited DENV infection in HeLa TIM-1 cells (Figure 6F)
and in human cells that endogenously express TIM-1 (Figure 6G)
without interfering with DENV translation and vRNA amplification
(Figure S6G). Consistent with these data, we observed that
silencing of HRS, a STAM-1 binding partner and component of
the ESCRT-0 complex, significantly reduced DENV infection
(Figure 6H).In conclusion, our study brings insights into the cell biology of
DENV entry. We provide several lines of evidence that TIM-1 is
an authentic DENV receptor required for virus binding and endo-
cytosis. Using a panel of complementary techniques, including
live-imaging TIRF microscopy, we analyzed the dynamics of
TIM-1-mediated entry of DENV. We propose that, when
adsorbed on the cell surface, DENV diffuses at the plasmamem-
brane until it reaches TIM-1 clusters, predominantly stuck in
preexisting CCPs, where TIM-1/DENV complexes will be rapidly
co-internalized. This is in agreement with previous reports
showing that DENV enters a host cell by rolling on the plasma
membrane to reach preexisting CCPs (van der Schaar et al.,
2007, 2008). In contrast to entry of Ebola virus (Moller-Tank
et al., 2014) or phagocytosisof apoptotic cells,DENVendocytosis
relies on the TIM-1 cytoplasmic tail. Tail-less TIM-1 molecules
have a defect in internalization and are unable to promote DENV
uptake. We demonstrate for the first time that TIM-1 is ubiquiti-
nated at K338 and K346 residues and that this post-translational
modification is required for DENV entry. Ubiquitination is a
well-known modification involved in the regulation of cell surface
proteins by promoting internalization and sorting toward late
endosome/lysosomes (Haglund and Dikic, 2012; Shih et al.,
2000). It hasbeen reported forEGFR that ligandbindingpromotes
ubiquitination and alters trafficking (Sigismund et al., 2005).
Because DENV predominantly fuses within late endosomes
(Smit et al., 2011; van der Schaar et al., 2008), it is tempting to
speculate that DENV binding to TIM-1 may stimulate sorting of
the receptor to late endosomes. Consistent with a role of TIM-1
ubiquitination in DENV entry, our proteomics analysis of TIM-1
binding partners identified various component of the Ubmachin-
ery as well as STAM-1 as a new host factor required for DENV
infection. Several PS receptors, including Axl and CD300a, have
been identified asDENV entry factors (Carnec et al., 2015;Meert-
ens et al., 2012) and might accomplish non-redundant functions
during DENV infection. CD300a acts as a DENVbindingmolecule
without promoting viral uptake (Carnec et al., 2015). Axl promotes
DENV entry and also induces intracellular signaling that dampens
innate immune responsesand favors viral replication (Bhattachar-
yyaet al., 2013;Chenet al., 2018;Meertenset al., 2012, 2017). It is
thus likely that these different PS receptors play complementary
roles during DENV entry. Moreover, we noticed that TIM-1 KO
cells are sensitive, at low levels, to DENV infection, indicating
that uncharacterized DENV receptor(s) remain to be identified.
We also report that TIM-1 is endogenously expressed in the
epidermis, mostly, if not exclusively, by keratinocytes of the
basal layer. Infection experiments of skin explants previously
revealed the presence of DENV-infected cells in this basal layer
(Limon-Flores et al., 2005). It is tempting to speculate that TIM-1
may serve as an early DENV receptor in the skin during mosquito
bites and may play a role in virus transmission. Targeting TIM-1
with antibodies or small molecules may provide effective flavivi-
rus antiviral agents by interfering with viral entry.EXPERIMENTAL PROCEDURES
Cells Lines and Viruses
HeLa, HEK293T, 769P, A549, and Huh7.5 cells were maintained in DMEM (Life
Technologies) supplemented with 10% fetal bovine serum (FBS), 1%Cell Reports 23, 1779–1793, May 8, 2018 1789
(legend on next page)
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penicillin-streptomycin, and L-Glutamine (Life Technologies). Cells stably
expressing TIM-1 or mutants were generated by transduction using pTRIP len-
tiviral vectors and sorted on a BD FACS Aria III (Becton Dickinson). DENV1
TVP5175, DENV2 JAM, DENV3 THAI, DENV4 1036, WNV, ZIKV HD78, and
HSV-1 viruses were produced as described previously (Meertens et al., 2012).
Endocytosis Assay
Cells were grown on Lab-Tek chamber slides and incubated with mouse anti-
TIM-1 (R&D Systems) primary Ab (30 mg/mL) with Tf Alexa Fluor A594-conju-
gated diluted at 1:50 (Life Technologies) or DENV2 AF594 at MOI 50 for 1 hr
at 4C. Cells were then washed with cold PBS and shifted to 37C. At different
time points, cells were fixedwith PBS-paraformaldehyde (PFA) (4%) for 15min
at room temperature (RT) and then stained with a secondary Ab, goat
anti-mouse Alexa Fluor 488, conjugated in the presence or absence of saponin
(0.05%) to distinguished external and internalized receptors. Images were
obtained by confocal microscopy (LSM700 Carl Zeiss, Jena).
Viral Internalization Assay
For immunofluorescence analysis, cells were seeded on Lab-Tek chamber
slides (Nunc, Roskilde, Denmark). For qRT-PCR vRNA quantification, cells
were seeded on 6-well plates. Cells were incubated with viral particles for
1 hr on ice, washed to remove unbound particles, and shifted to 37C for
30min or 2 hr. Cells were either treated or not with trypsin for 15min or protein-
ase K (1 mg/mL) for 45 min on ice to remove non-internalized particles.
Live Microscopy and Data Analysis
For TIRF microscopy, cells were seeded on MatTek dishes (MatTek) and live
cells were imagedwith a Zeiss LSM780 Elyra TIRFmicroscope using ZEN soft-
ware. For clathrin imaging, TIM-1 GFP cells were transfected for 48 hr with a
plasmid expressing CLC-dsRed before imaging. For monitoring DENV2
AF594 internalization, TIM-1 GFP, TIM-1 Dcyt GFP, or TIM-1 KKRR GFP
were imaged in the continuous presence of DENV2 AF594 at 37C. Trajec-
tories and fluorescence intensities of TIM-1 GFP and DENV2 AF594 spots
were analyzed by computational analysis with TrackMate (Tinevez et al.,
2017) and MATLAB (MathWorks). Quantification of DENV2 AF594 spots was
assessed using Fiji software.
For live-cell confocal microscopy, cells were seeded on MatTek dishes, and
images were acquired for 20 min at 1 image per 2 s on a spinning disk micro-
scope (UltraVIEW VOX, PerkinElmer) in the continuous presence of DENV2
AF594. Quantification was assessed using Fiji software.
Transmission Electron Microscopy
For standard transmission electron microscopy, cells were scraped and fixed
by incubation for 24 hr in 4% PFA and 1% glutaraldehyde (Sigma, St. Louis,
MO) in 0.1 M phosphate buffer (pH 7.2). Samples were then washed in PBS
and post-fixed by incubation with 2% osmium tetroxide (Agar Scientific,
Stansted, UK) for 1 hr. Samples were then fully dehydrated in a graded series
of ethanol solutions and propylene oxide. The impregnation step was per-
formed with a mixture of (1:1) propylene oxide/Epon resin (Sigma) and thenFigure 6. STAM Interacts with TIM-1 and Is Important for DENV Infecti
(A) Parental or HeLa cells expressing TIM-1 WT, Dcyt, or KKRR were transientl
lysates were subjected to immunoprecipitation (IP) using goat anti-TIM-1 antib
analysis using mouse anti-FLAG M2 antibody.
(B) Confocal microscopy images of TIM-1 GFP and endogenous STAM in fixed ce
0.605 ± 0.06. Scale bar, 10 mm.
(C) Validation of STAM protein knockdown by immunoblot analysis.
(D) HeLa TIM-1 cells transfected with siRNA NT (blue) or targeting STAM (purple) w
cells stained with a control Ab.
(E) Parental or TIM-1 HeLa cells were transfected with the indicated siRNA. Cells w
or not treated with trypsin. Cells were then fixed and stained for DENV viral RNA (r
three independent experiments (n > 30). Scale bar, 10 mm. Right: quantification
(F and G) HeLa TIM-1 cells (F) or the 769P and A549 cell lines (G) were transfected
JAM. The percentage of infected cells was assessed 24 hpi using 2H2 antibody.
(H) HeLa TIM-1 cells were transfected with siRNA NT or targeting Hrs and analy
Data are shown as mean ± SD of at least two independent experiments. For (D)
(**p < 0.001, ***p < 0.0001).left overnight in pure resin. Cells were then embedded in Epon resin (Sigma),
which was allowed to polymerize for 48 hr at 60C. Ultra-thin sections
(90 nm) of these blocks were obtained with an EM UC7 ultramicrotome (Leica
Microsystems, Wetzlar, Germany). Sections were stained with 2% uranyl
acetate (Agar Scientific) and 5% lead citrate (Sigma), and observations were
made with a transmission electron microscope (JEOL 1011, Tokyo, Japan).
Immunogold Labeling of Cryosections According to the Tokuyasu
Method for Immunoelectron Microscopy
Cells were fixed for 2 hr with 4%PFA in phosphate buffer (pH 7.6), washedwith
PBS (pH 7.6) twice for 5 min each time, and centrifuged at 3003 g for 10 min.
After removing the supernatant, cell pellets were included in gelatin (12%) and
infused with sucrose (2.3 M) overnight at 4C. 90-nm ultra-thin cryosections
were made at 110C on a Leica Microsystems FC7 cryo-ultramicrotome.
Sections were retrieved with a methylcellulose (2%)/sucrose (2.3 M) mixture
(1:1) and collected onto formvar/carbon-coated nickel grids. After removal
of gelatin at 37C, sections were incubated with PBS containing 1:100 anti-
TIM-1 and 1:100 anti-DENV. After six washes of PBS (5 min each), the grids
were incubated with PBS containing 1:30 gold-conjugated goat-anti-mouse
(6 nm) and 1:30 goat-anti-rabbit IgG (10 nm) (Aurion, Wageningen, the
Netherlands). The grids were finally washed in PBS (six washes of 5 min
each), post-fixed in 1% glutaraldehyde, and rinsed with distilled water. The
contrasting step was performed by incubating grids in a 2% uranyl acetate/
2%methylcellulose mixture (1:10). The sections were imaged with a transmis-
sion electron microscope at 100 kV (JEOL 1011).
Statistical Analysis
Graphical representation and statistical analyses were performed using
Prism5 software (GraphPad). Unless otherwise stated, results are shown as
means ± SD from three independent experiments. Differences were tested
for statistical relevance using unpaired two-tailed t test or one-way ANOVA
with Tukey post-test. Pierson correlation coefficient (PCC) was calculated
using the ImageJ plugin Coloc2 and is represented as the mean ± SEM.
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